Deficiency in Mfn1 or Mfn2 expression disrupts mitochondrial structure, promoting cardiomyocyte hypertrophy and heart failure, and significantly inhibiting the expression of mitochondrial biogenesis-related proteins (PGC-1α and Nrf-1) [71]. Here, PPARGC1A is linked to heart failure.